Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
US7875610B2 · kind B2 · utility
10Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2008 |
| Grant date | Jan 25, 2011 |
| Priority date | — |
| Expiry date | Dec 3, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new dopamine D3 and D2 ligands of formula (I):wherein R1, R2 and Q are as described herein, and/or geometric isomers and/or stereoisomers and/or diastereomers and/or salts and/or hydrates and/or solvates and/or polymorphs thereof. The invention also relates to processes for preparing the same, to compositions containing the same and to their use in the treatment and/or prevention of conditions which requires modulation of dopamine receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.